Mission
Pharmacovigilance and hospital acquired infection control - International Summer School
was born from a desire of cooperation between an Italo- American excellence
consortium, involving the Sbarro Institute for Cancer Research and Molecular Medicine
(USA) and the Pharmacological Risk Unit Medigenia (IT).
Chief of the initiative is prof. Antonio Giordano, head of the US Research Institute, a
world-renowned scientist and recently awarded of the ‘Grand Hippocrate’
Prize.
The Summer School was founded with the goal of providing an advanced scientific
training, which is essential to enable the participants to succeed and compete effectively
in healthy fields.
Program
The program promotes intercultural and professional dialogue approach and the
fulfillment of individual potential active in the context of a multidisciplinary dimension.
The Summer School will be held at the Sbarro Institute for Cancer Research and
Molecular, Philadelphia (USA).
It is divided into three days full time, 5 to 7 August 2013, during which will be
discussed the aspects that concern pharmacovigilance and its implications in Good
Clinical Practice, as well as the increasingly topical. and thorny problem of hospital
infections.
Expectation
The educational cut given by the scientific committee encourages advanced research
‘forma mentis’, thus providing not only what is purely notional, but a top class approach
centered on patient care as a unique individual. The young participants will acquire,
through the simulations of clinical cases and ex-cathedra lectures, an increasing ability,
decision-making autonomy and self- assertion in each own scientific reality.
Official language will be English.
Applications and fees
Admission decisions to the School are based on the totality of available information
about each applicant, and a careful evaluation of the candidate’s past accomplishments
and future promise. We have no mechanical shortcuts or substitutes for careful
consideration of each applicant.
The maximum number of participants is 25.
Candidates will be selected among the students enrolled in the last academic year of the
Faculty of Medicine and Surgery, Biology/Biotechnology and Pharmacy, specializing/ed
in medical areas as well as physicians, biologist and pharmacists graduated no more
than 5 years coming from EU Countries.
The cost of participation in the 'Pharmacovigilance and hospital acquired infection
control- Summer School' is 1,500€ and includes the training material, the use of the
library and ISCTE service facilities, certificate of attendance (with EBM credits) coffee
breaks, lunch catering, the Gala Dinner and Philadelphia’s city tour.
It's possible to join a full package, which includes the travel and accommodation full
board in Philadelphia (total cost 2,500€).
Participants may also apply for Summer School scholarship (750€ each one) fully
filling the Application Form.
Applications will be accurately sized up and within 5 day from transmission every
participant will receive a notification about acceptance or not.
To make effective the application after acceptance, the participant must pay the fee
using the following bank details:
Infostruttura onlus, via della Stanga 18, Gradisca d’Isonzo (Go), Italy
Swift /BIC code: UNCRITM1M27
Iban code: IT 84 I 02008 59550 000 100829680
ABI: 02008
CAB: 59550
Account number: 100829680
Reason of payment: Summer School
Should you need any further information or assistance please contact [email protected].
Program
5 August 2013
8.30-9.00 am Registration
9.00-9.30 am Prof. Antonio Giordano
Director of Sbarro Institute for Cancer Research and Molecular Medicine
Greetings from the President to incoming students: ’our objective is not to train students, but for them to
train themselve’.
9.30-10.00 am Dr. Silvia Ussai
Director of Pharmaceutical Risk Unit ‘Medigenia’
Epidemiology of Adverse Drug Reaction (ADR): reasons behind underestimation and clinical relevance.
11.00-11.30 am Prof. Giuseppe Russo
Director of the Cancer Systems Biology and eHEALTH Programs, Sbarro Institute for Cancer Research and
Molecular Medicine, Temple University
Molecular biology in moving towards a personalized medicine.
10.00-11.00 am Dr. Silvia Ussai
Director of Pharmaceutical Risk Unit ‘Medigenia’
Skin lesions radiation- induced: the role of Water-Jel
11.30-12.00 am Coffee Break
12.00 am-12.30 pm Eng. Riccardo Petelin
Risk Manager and CEO Medigenia srl
Medigenia: a free health service that prevents ADRs using the social security number .
12.30 am-1.00 pm Dr. Fatima Morale Marin
Medical Science Researcher, University of Granada, Spain
Collaboration between Pharma Company and University
1.00-2.00 pm Lunch
2.00-3.00 pm Dr. Silvia Ussai
Director of Pharmaceutical Risk Unit ‘Medigenia’
Clinical cases simulation
With the contribution of
3.0-3.30 pm Prof. Eva Surmacz
Director, Obesity and Cancer, Sbarro Institute for Cancer Research and Molecular Medicine, Temple
University
Cardiovascular pharmocovigilance in Diabetes Research part 1
3.30-5.00 pm Discussion
8.00 pm Tour of the city
6 August 2013
9.30-10.30 am Eng. Riccardo Petelin
Risk Manager and CEO Medigenia srl
New tools to classify pharmacological risk.
10.30-11.00 am Prof. Marcella Macaluso
Director of Epigenetics and Genetics, Sbarro Institute for Cancer Research and Molecular Medicine, Temple
University
Oncology and epigenetics: an approach towards pharmacovigilance
11.00-11.30 Coffee break
11.30-12.00 am Dr. Silvia Ussai
Director of Pharmaceutical Risk Unit ‘Medigenia’
Over The Couter and alternative medicine surveillance.
12.00 am-1.00 pm Eng. Riccardo Petelin
Risk Manager and CEO Medigenia srl
Avoiding ADRs to make cheaper health insurance?
1.00-2.00 pm
Lunch
2.00-3.00 pm Dr. Silvia Boffo
Lead Scientist, CRO Aviano, Italy
Drug design and testing in animal models
3.00-4.00 pm Dr. Fatima Morales Marin
Medical Researcher, University of Granada, Spain
Oncology: pharmacovigilance in clinical practice.
4.00-5.00 pm Speakers Round Table
8.00 pm Gala dinner
7 August 2013
9.30-10.00 am Dr. Silvia Ussai
Director of Pharmaceutical Risk Unit ‘Medigenia’
Hospital acquired infections: incidence, prevalence, morbidity, mortality.
10.00-10.30 am Prof. Giuseppe Russo
Director of the Cancer Systems Biology and eHEALTH Programs, Temple University
Antimicrobial resistance: molecular mechanisms and recent study results.
10.30-11.00 am Dr. Fatima Morales Marin
Researcher, University of Granada, Spain
Pharmacovigilance in Europe: the Spain model
11.00-11.30 Coffee break
11.30-12.00 am Prof. Marcella Macaluso
Director of Epigenetics and Genetics, Sbarro Institute for Cancer Research and Molecular Medicine, Temple
University
Nutrigenomics and pharmacovigilance: state of art
12.00 am-12.30 pm Prof. Eva Surmacz
Director, Obesity and Cancer, Sbarro Institute for Cancer Research and Molecular Medicine, Temple
University
Cardiovascular pharmocovigilance in Diabetes Research part 2
12.30 am-1.00 pm Dr. Silvia Boffo
Lead Scientist, CRO Aviano, Italy
Drug response prediction in polypharmacy
1.00-2.00 pm Lunch
2.00-3.00 pm Discussion and closing remarks
Application Form for Admission
Section A: Your Personal Details
Please enter your name exactly as it appears on your passport or other official document.
FAMILY NAME TITLE (Mr, Mrs, Ms, Miss, etc.)
FIRST NAME GENDER: MALE FEMALE
MIDDLE NAME(S) DATE OF BIRTH: day _ _ / month _ _ / year _ _ _ _
PREFERRED NAME
Section B: Contact Information
HOME ADDRESS CORRESPONDENCE ADDRESS (if different)
CITY: CITY:
POSTAL/ZIP CODE: POSTAL/ZIP CODE:
STATE: STATE
COUNTRY: COUNTRY:
TELEPHONE (if you give more than one, please indicate which is the primary contact number)
TYPE
(mobile/cell phone,
daytime, evening, etc)
COUNTRY CODE
(if outside USA)
AREA CODE NUMBER
EMAIL ADDRESS (if you give more than one, please indicate which is the primary address)
Section C: Nationality & Citizenship
COUNTRY OF BIRTH:
COUNTRY OF NATIONALITY/CITIZENSHIP
Please include all countries that you have nationality of and give an effective date if you have not been a
national of that country from birth. Please do not give an end date unless your nationality of that country
has ended. Please give the number, nationality and expiry date of the passport that you intend to use to
enter the USA.
COUNTRY FROM (dd/mm/yyyy) TO (dd/mm/yyyy) PASSPORT NUMBER
AND EXPIRY DATE
(dd/mm/yyyy)
COUNTRY OF RESIDENCE
Please give details for the past 6 years. This should be the country in which you are normally resident not the country in
which you are studying. Please do not give an end date unless you no longer reside in that country.
COUNTRY FROM (dd/mm/yyyy) TO (dd/mm/yyyy)
Section D: Curriculum Vitae et studiorum
I’ve attached CV
Yes No
Section E: Scholarship
Medigenia and SHRO offer scholarships to help young doctors and scientists participate in the Summer School.
Each scholarship has a value of EUR 750,00. In order to qualify to be considered for a scholarship, you must fulfil the
following criteria:
Apply for Summer School
Be aged less than 35 years old
Provide a letter of support from your Department Head
Please send Application Form and personal CV to infomedigenia.com.
You will receive a confirmation about acceptance in the Summer School and scholarship within 5 days.
Declaration Once you have completed this application form, please read the following statements carefully. By signing this application form you confirm your acceptance of these statements. If you do not sign this form, we cannot process your application. I confirm that the information I have provided on this application form is (to the best of my knowledge) true, accurate, current and complete; and I agree to notify the SHRO/Medigenia promptly if any information contained on this application form should change, in order to keep it true, accurate, current and complete. I confirm that all supporting work submitted as part of this application is entirely my own original work, except where clearly indicated otherwise, and does not include any plagiarised elements. SIGNATURE:
DATE:
SIGNED (PLEASE PRINT NAME):